Viscom AG (V6C)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 6.500 |
|---|---|
| 52-week range | 3.640 – 6.800 |
| Return, 1 month / 3 months | +30.0% / +28.5% |
| Return, 1 year / 3 years | +12.1% / −11.8% |
| Trend | Uptrend |
| RSI (14) | 82 |
| Volatility (1 year) | 57.8% |
| Worst drawdown (1 year) | -33.9% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viscom AG is a German company based in Hanover that builds automated inspection systems for electronics manufacturing. Its machines use optical and X-ray imaging to check printed circuit boards, verifying solder joints, component placement and overall assembly quality. Customers are electronics producers and contract manufacturers who use the equipment to catch defects during production. The company supplies inspection hardware along with the software and services that support it, and it works with manufacturers in many countries.
Viscom AG trades under the code V6C on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Viscom AG (V6C) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 6.500 on 27 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 296 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.1% and over the last three months it rose 28.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 29.8% | ||
| From 52-week high | -3.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.5% | ||
| 6-month return | 53.7% | ||
| 12-month return, skipping the last month | -13.8% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.9% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +30.3% |
|---|---|
| 1 month | +30.0% |
| 3 months | +28.5% |
| 6 months | +53.7% |
| 1 year | +12.1% |
| 3 years | −11.8% |
| 5 years | −39.5% |
Signals
| 50-day / 200-day average | 5.323 / 5.009 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.260 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 May 2024 | EUR 0.0500 |
| 1 Jun 2023 | EUR 0.3000 |
| 9 Jun 2022 | EUR 0.2000 |
| 5 Aug 2020 | EUR 0.0500 |
| 29 May 2019 | EUR 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.